Levodopa Side Effects
Levodopa causes both motor complications (dyskinesias, motor fluctuations) and a wide range of nonmotor side effects including nausea, orthostatic hypotension, neuropsychiatric symptoms, and gastrointestinal disturbances, with most motor complications developing after more than 5 years of therapy. 1
Motor Complications
The most prominent adverse effects are motor complications, which typically emerge after prolonged therapy:
- Dyskinesias (choreiform, dystonic, and other involuntary movements) are the most common motor complication 1
- Motor fluctuations including "wearing-off" phenomenon and "on-off" episodes occur in approximately 30% of patients within the first 2 years, with most patients experiencing these after more than 5 years 2
- Motor complications develop in relation to disease progression and duration of exposure, not necessarily the timing of levodopa initiation 3, 4
Gastrointestinal Side Effects
Nausea and vomiting are among the most common early side effects, though these are significantly reduced when levodopa is combined with carbidopa (a peripheral decarboxylase inhibitor) 1. Other gastrointestinal effects include:
- Anorexia, vomiting, diarrhea, constipation
- Gastrointestinal bleeding and duodenal ulcer development
- Dyspepsia, dry mouth, taste alterations
- Dark saliva 1
Cardiovascular Effects
Levodopa causes multiple cardiovascular side effects 1:
- Orthostatic hypotension and other orthostatic effects
- Cardiac irregularities and palpitations
- Hypertension, syncope
- Phlebitis
Neuropsychiatric Complications
Behavioral and psychiatric symptoms represent a significant burden and include 1, 5:
- Psychotic episodes with delusions, hallucinations, and paranoid ideation
- Confusion, agitation, anxiety
- Depression (with or without suicidal tendencies)
- Dementia
- Impulse control disorders including pathological gambling, hypersexuality, and increased libido
- Dopamine dysregulation syndrome and compulsive behaviors (punding)
- Hypomania and mania
- Sleep disturbances including insomnia, nightmares, and dream abnormalities
- Somnolence and dizziness
These behavioral symptoms are often underdiagnosed despite their significant impact on quality of life 5.
Hematologic Effects
Blood-related side effects include 1:
- Agranulocytosis
- Hemolytic and nonhemolytic anemia
- Thrombocytopenia
- Leukopenia
- Decreased hemoglobin and hematocrit
Other Significant Side Effects
- Hypersensitivity reactions: angioedema, urticaria, pruritus, bullous lesions 1
- Dermatologic: rash, increased sweating, alopecia, dark sweat, malignant melanoma 1
- Urogenital: urinary frequency, urinary retention, urinary incontinence, priapism, dark urine 1
- Musculoskeletal: muscle cramps, back pain, shoulder pain 1
- Respiratory: dyspnea, upper respiratory infection 1
- Laboratory abnormalities: elevated liver enzymes (AST, ALT, alkaline phosphatase), abnormal bilirubin, elevated serum glucose, positive Coombs test 1
Important Clinical Considerations
Dose-related effects: Higher doses of levodopa and advanced Hoehn and Yahr stage are the most significant risk factors for adverse reactions, not the duration of therapy or early initiation 4. This supports using the minimum effective dose even when combining with other anti-parkinsonian medications.
Protein interaction: Levodopa competes with amino acids for gut absorption, so high-protein diets may impair absorption 1.
Vitamin B6 interaction: Pyridoxine (10-25 mg) can reverse levodopa effects by increasing peripheral decarboxylation, though this is blocked when carbidopa is co-administered 1.
Abrupt withdrawal risk: Sudden discontinuation of dopaminergic agents should be avoided 6.
Age considerations: Elderly patients (≥65 years) show 28% higher systemic exposure (AUC) and 24% higher peak concentrations compared to younger patients, potentially increasing side effect risk 1.